The tumor suppressor gene BMP5 has been investigated in myeloma, adrenocortical carcinoma, and breast cancer, and Chen et al. (38) reported that loss of BMP5 is an early event in CRC, and that low BMP5 expression was associated with recurrence and poorer prognoses. The gene discussed is BMP5; the disease is plasma cell myeloma.